Shenzhen - Delayed Quote CNY

Landfar Bio-medicine Co., Ltd (000504.SZ)

6.93 +0.09 (+1.32%)
At close: April 26 at 3:04 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
148,700.73
200,345.46
156,618.31
175,564.99
Cost of Revenue
44,153.68
70,538.09
45,683.42
78,083.33
Gross Profit
104,547.05
129,807.37
110,934.89
97,481.66
Operating Expense
109,673.20
117,609.14
106,934.48
73,049.76
Operating Income
-5,126.14
12,198.23
4,000.40
24,431.89
Net Non Operating Interest Income Expense
-9,364.61
-11,586.73
-13,988.78
-3,292.76
Pretax Income
-28,696.45
-21,559.42
-30,227.61
18,967.73
Tax Provision
4,515.65
8,202.00
2,873.43
4,332.26
Net Income Common Stockholders
-12,748.78
-12,694.78
-19,125.95
8,154.55
Basic EPS
-0.04
-0.04
-0.06
0.03
Diluted EPS
-0.04
-0.04
-0.06
0.03
Basic Average Shares
306,965.08
317,369.40
318,765.84
271,818.36
Diluted Average Shares
306,965.08
317,369.40
318,765.84
271,818.36
Total Operating Income as Reported
-29,672.75
-26,149.34
-30,665.03
18,943.69
Rent Expense Supplemental
1,591.10
805.02
820.90
1,335.96
Total Expenses
153,826.88
188,147.22
152,617.90
151,133.10
Net Income from Continuing & Discontinued Operation
-12,748.78
-12,694.78
-19,125.95
8,154.55
Normalized Income
-662.62
7,378.92
-3,736.12
9,904.47
Interest Income
1,389.03
1,776.97
2,461.34
138.87
Interest Expense
9,552.04
11,867.81
14,114.39
4,012.04
Net Interest Income
-9,364.61
-11,586.73
-13,988.78
-3,292.76
EBIT
-19,144.41
-9,691.60
-16,113.22
22,979.77
EBITDA
-19,144.41
-3,479.38
-9,241.90
26,334.05
Reconciled Cost of Revenue
44,153.68
70,538.09
45,683.42
78,083.33
Reconciled Depreciation
--
6,212.23
6,871.32
3,354.27
Net Income from Continuing Operation Net Minority Interest
-12,748.78
-12,694.78
-19,125.95
8,154.55
Total Unusual Items Excluding Goodwill
-16,114.87
-26,764.93
-20,519.77
-2,267.92
Total Unusual Items
-16,114.87
-26,764.93
-20,519.77
-2,267.92
Normalized EBITDA
-3,029.54
23,285.55
11,277.87
28,601.97
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-4,028.72
-6,691.23
-5,129.94
-518.00
12/31/2020 - 12/8/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

603896.SS Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
26.44
+4.84%
 
603739.SS Qingdao Vland Biotech INC.
11.46
+9.98%
 
603439.SS Guizhou Sanli Pharmaceutical Co.,Ltd
15.43
+0.78%
 
002566.SZ Jilin Jian Yisheng Pharmaceutical Co., Ltd.
6.86
-3.65%
 
603229.SS Zhejiang Ausun Pharmaceutical Co., Ltd.
10.49
+0.87%
 
603718.SS Shanghai Hile Bio-Technology Co., Ltd.
8.13
-0.73%
 
000710.SZ Berry Genomics Co.,Ltd
8.18
+0.99%
 
603590.SS Beijing Konruns Pharmaceutical Co.,Ltd.
29.48
-0.37%
 
002630.KS ORIENT BIO Inc.
526.00
-1.13%
 
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
21.20
+2.27%